secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001193125-25-125833
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma shareholders OK share increase to 800M, re-elect directors
------------------------------------------------------------------------

- Authorized common shares increased from 400M to 800M; approved by 65.5M votes for vs 7.7M against.
- Class I directors Matthew Patterson and Daniella Beckman re-elected with ~53.4M and ~52.7M votes for.
- Ernst & Young LLP ratified as independent auditor for FY2025 with 73.1M votes for.
- Annual meeting had 73.2M shares represented, ~58.7% of outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525125833/0001193125-25-125833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312525125833/d95113d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-125833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer